| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 0 | 22.065 | - | 12.818 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total Income - EUR | 0 | 35.000 | - | 12.819 | 1 | 0 | 0 | 0 | 0 | 0 |
| Total Expenses - EUR | 0 | 49.573 | - | 2.135 | 2.190 | 2.748 | 898 | 175 | 207 | 170 |
| Gross Profit/Loss - EUR | 0 | -14.573 | - | 10.684 | -2.189 | -2.748 | -898 | -175 | -207 | -170 |
| Net Profit/Loss - EUR | 0 | -15.235 | - | 10.282 | -2.189 | -2.748 | -898 | -175 | -207 | -170 |
| Employees | 0 | 0 | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Check the financial reports for the company - Enmed Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 24.709 | 1.285 | - | 3.353 | 2.278 | 1.244 | 670 | 609 | 545 | 480 |
| Current Assets | 12.557 | 1.639 | - | 1.992 | 2.034 | 1.569 | 1.670 | 1.705 | 1.700 | 1.690 |
| Inventories | 88 | 0 | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Receivables | 12.434 | 1.615 | - | 1.712 | 1.944 | 1.499 | 1.466 | 1.516 | 1.511 | 1.503 |
| Cash | 36 | 24 | - | 281 | 89 | 69 | 204 | 189 | 188 | 187 |
| Shareholders Funds | -35.756 | -51.956 | - | -39.466 | -40.891 | -42.863 | -42.811 | -43.120 | -43.196 | -43.124 |
| Social Capital | 45 | 45 | - | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | 73.022 | 54.879 | - | 44.812 | 45.202 | 45.676 | 45.151 | 45.433 | 45.440 | 45.294 |
| Income in Advance | 0 | 0 | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8623 - 8623" | |||||||||
| CAEN Financial Year |
8623
|
|||||||||
Comments - Enmed Srl